Goldfinch Biopharma

About:

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

Website: https://www.goldfinchbio.com/#home

Twitter/X: goldfinchbio

Top Investors: BlackRock, Wellington Management, Gilead Sciences, Third Rock Ventures, Eventide

Description:

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. It is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease. Its Product Engine will industrialize the integration of genetics and kidney biology and confer a differentiated ability to identify, validate, and pursue novel therapeutic targets to treat progressive kidney disease. The company was founded in 2016 and is based in Cambridge, Massachusetts.